drugset / Trial / NCT07118579

Effects of Remimazolam and Ciprofol TIVA on PRAE in Pediatric Tonsillectomy and Adenoidectomy

NCT07118579

Phase 4 Recruiting 114 enrolled Tongji Hospital
RandomizedParallel-groupDouble-blindPrevention

Summary

To observe the effects of remimazolam versus ciprofol TIVA on PRAE in pediatric tonsillectomy and adenoidectomy.

Timeline

Start
2025-09-23
Primary completion
2026-08
Completion
2026-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Cipepofol Small molecule 0.8 mg/kg
Subject Cipepofol Small molecule 1.2 mg/kg
Comparator Propofol Small molecule 6 mg/kg
Comparator Propofol Small molecule 10 mg/kg
Subject Remimazolam Small molecule 1 mg/kg
Subject Remimazolam Small molecule 3 mg/kg

Indications

No indication recorded.